224 related articles for article (PubMed ID: 291947)
21. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.
Fernandez HN; Hugli TE
J Biol Chem; 1978 Oct; 253(19):6955-64. PubMed ID: 690134
[TBL] [Abstract][Full Text] [Related]
22. The active site of C3a anaphylatoxin.
Caporale LH; Tippett PS; Erickson BW; Hugli TE
J Biol Chem; 1980 Nov; 255(22):10758-63. PubMed ID: 6968751
[TBL] [Abstract][Full Text] [Related]
23. Purification and partial amino acid sequence of classical anaphylatoxin from pig serum: identification with Des-Arg-C5a.
Zimmermann B; Damerau B; Vogt W
Hoppe Seylers Z Physiol Chem; 1980; 361(6):915-24. PubMed ID: 7399411
[TBL] [Abstract][Full Text] [Related]
24. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids.
Wagner JL; Hugli TE
Anal Biochem; 1984 Jan; 136(1):75-88. PubMed ID: 6711816
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.
Huey R; Bloor CM; Kawahara MS; Hugli TE
Am J Pathol; 1983 Jul; 112(1):48-60. PubMed ID: 6859228
[TBL] [Abstract][Full Text] [Related]
26. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
27. Anaphylatoxin levels in human aqueous humor.
Mondino BJ; Sumner H
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
[TBL] [Abstract][Full Text] [Related]
28. C4a: An Anaphylatoxin in Name Only.
Barnum SR
J Innate Immun; 2015; 7(4):333-9. PubMed ID: 25659340
[TBL] [Abstract][Full Text] [Related]
29. Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction.
Stimler-Gerard NP; Galli SJ
J Immunol; 1987 Mar; 138(6):1908-13. PubMed ID: 2434565
[TBL] [Abstract][Full Text] [Related]
30. Complement anaphylatoxins in idiopathic mixed cryoglobulinemia.
Miadonna A; Leggieri E; Tedeschi A; Cottini M; Invernizzi F; Froldi M; Zanussi C
Int Arch Allergy Appl Immunol; 1985; 76(2):120-5. PubMed ID: 3967939
[TBL] [Abstract][Full Text] [Related]
31. Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses.
Takematsu H; Ohkohchi K; Tagami H
Br J Dermatol; 1986 Jan; 114(1):1-6. PubMed ID: 3484631
[TBL] [Abstract][Full Text] [Related]
32. Human C5a des Arg increases vascular permeability.
José PJ; Forrest MJ; Williams TJ
J Immunol; 1981 Dec; 127(6):2376-80. PubMed ID: 6170701
[TBL] [Abstract][Full Text] [Related]
33. Plasma anaphylatoxin concentrations in inflammatory skin diseases.
Terui T; Takematsu H; Kato T; Ohkohchi K; Tagami H
Tohoku J Exp Med; 1987 Feb; 151(2):245-52. PubMed ID: 3495048
[TBL] [Abstract][Full Text] [Related]
34. Primary structure of bovine complement activation fragment C4a, the third anaphylatoxin. Purification and complete amino acid sequence.
Smith MA; Gerrie LM; Dunbar B; Fothergill JE
Biochem J; 1982 Nov; 207(2):253-60. PubMed ID: 6760852
[TBL] [Abstract][Full Text] [Related]
35. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
Sorgenfrei J; Damerau B; Vogt W
Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
[TBL] [Abstract][Full Text] [Related]
36. Anaphylatoxin levels in human vitreous humor.
Mondino BJ; Sidikaro Y; Sumner H
Invest Ophthalmol Vis Sci; 1988 Jul; 29(7):1195-8. PubMed ID: 3262096
[TBL] [Abstract][Full Text] [Related]
37. Anaphylatoxin generation in multisystem organ failure.
Heideman M; Hugli TE
J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
[TBL] [Abstract][Full Text] [Related]
38. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.
Nagata S; Glovsky MM
J Allergy Clin Immunol; 1987 Jul; 80(1):24-32. PubMed ID: 3496373
[TBL] [Abstract][Full Text] [Related]
39. Effects of human anaphylatoxins on guinea pig atria.
Huey R; Bloor CM; Hugli TE
Immunopharmacology; 1984 Dec; 8(3-4):147-54. PubMed ID: 6335143
[TBL] [Abstract][Full Text] [Related]
40. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]